Future Oncology
Volume 18, 2022 - Issue 19
Open access
7,468
Views
19
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol
Multicenter phase II trial of trastuzumab deruxtecan for HER2-positive unresectable or recurrent biliary tract cancer: HERB trial
Akihiro Ohba1 Department of Hepatobiliary & Pancreatic Oncology,National Cancer Center Hospital,Tokyo,
Japan
https://orcid.org/0000-0002-9153-3798View further author information
Chigusa Morizane1 Department of Hepatobiliary & Pancreatic Oncology,National Cancer Center Hospital,Tokyo,
JapanCorrespondence[email protected]
View further author information
, View further author information
Makoto Ueno2 Division of Hepatobiliary & Pancreatic Oncology,Kanagawa Cancer Center,Yokohama,
JapanView further author information
, Satoshi Kobayashi2 Division of Hepatobiliary & Pancreatic Oncology,Kanagawa Cancer Center,Yokohama,
JapanView further author information
, Yasuyuki Kawamoto3 Department of Gastroenterology & Hepatology,Hokkaido University Hospital,Sapporo,
Japan
https://orcid.org/0000-0002-7706-0015View further author information
Yoshito Komatsu4 Department of Cancer Chemotherapy,Hokkaido University Hospital Cancer Center,Sapporo,
JapanView further author information
, Masafumi Ikeda5 Department of Hepatobiliary & Pancreatic Oncology,National Cancer Center Hospital East,Kashiwa,
JapanView further author information
, Mitsuhito Sasaki5 Department of Hepatobiliary & Pancreatic Oncology,National Cancer Center Hospital East,Kashiwa,
JapanView further author information
, Naohiro Okano6 Department of Medical Oncology,Kyorin University Faculty of Medicine,Tokyo,
Japan
https://orcid.org/0000-0002-4098-5217View further author information
Junji Furuse6 Department of Medical Oncology,Kyorin University Faculty of Medicine,Tokyo,
JapanView further author information
, Nobuyoshi Hiraoka7 Division of Pathology & Clinical Laboratories,National Cancer Center Hospital,Tokyo,
JapanView further author information
, Hiroshi Yoshida7 Division of Pathology & Clinical Laboratories,National Cancer Center Hospital,Tokyo,
JapanView further author information
, Aya Kuchiba8 Biostatistics Section, Clinical Research Support Office, National Cancer Center Hospital/Biostatistics Division, Center for Research Administration & Support,National Cancer Center,Tokyo,
JapanView further author information
, Ryo Sadachi8 Biostatistics Section, Clinical Research Support Office, National Cancer Center Hospital/Biostatistics Division, Center for Research Administration & Support,National Cancer Center,Tokyo,
JapanView further author information
, Kenichi Nakamura9 Clinical Research Support Office,National Cancer Center Hospital,Tokyo,
JapanView further author information
, Naoko Matsui9 Clinical Research Support Office,National Cancer Center Hospital,Tokyo,
JapanView further author information
, Yoshiaki Nakamura10 Department of Gastroenterology & Gastrointestinal Oncology,National Cancer Center Hospital East,Kashiwa,
JapanView further author information
, Wataru Okamoto11 Cancer Treatment Center,Hiroshima University Hospital,Hiroshima,
JapanView further author information
, Takayuki Yoshino10 Department of Gastroenterology & Gastrointestinal Oncology,National Cancer Center Hospital East,Kashiwa,
JapanView further author information
& Takuji Okusaka1 Department of Hepatobiliary & Pancreatic Oncology,National Cancer Center Hospital,Tokyo,
JapanView further author information
show all
Pages 2351-2360
|
Received 26 Feb 2022, Accepted 20 Apr 2022, Published online: 05 May 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.